marketcap
Biohaven Pharmaceutical Holding Company Ltd. BHVN
$ 36.29
2.69%
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2022-Q2
added 12-16-2023
Biohaven Pharmaceutical Holding Company Ltd. Financial Statements 2011-2024 | BHVN
Annual Financial Statements Biohaven Pharmaceutical Holding Company Ltd.
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
8.59 B | 5.01 B | 2.35 B | 1.56 B | 962 M | - | - | - | - | - | - |
Shares |
64.7 M | 58.7 M | 48.5 M | 40.9 M | 27.8 M | - | - | - | - | - | - |
Historical Prices |
133 | 85.2 | 48.5 | 38.1 | 34.6 | - | - | - | - | - | - |
Net Income |
-847 M | -767 M | -529 M | -241 M | -127 M | -63.7 M | -10.1 M | - | - | - | - |
Revenue |
463 M | 63.6 M | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
91.7 M | 17.7 M | - | - | - | - | - | - | - | - | - |
Gross Profit |
371 M | 45.9 M | - | - | - | - | - | - | - | - | - |
Operating Income |
-704 M | -645 M | -479 M | -48.1 M | -108 M | -60.6 M | -9.7 M | - | - | - | - |
Interest Expense |
-7.26 M | -4.02 M | -22 K | -156 K | -906 K | 385 K | -370 K | - | - | - | - |
EBITDA |
-679 M | -636 M | -478 M | -47.8 M | -108 M | -63.1 M | -9.7 M | - | - | - | - |
Operating Expenses |
1.07 B | 691 M | 479 M | 225 M | 108 M | - | - | - | - | - | - |
General and Administrative Expenses |
714 M | 462 M | 134 M | 34.6 M | 18.1 M | 5.11 M | 2.14 M | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement Biohaven Pharmaceutical Holding Company Ltd.
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
- | - | 71 M | 70.3 M | 66.9 M | 65.4 M | 65.1 M | 62 M | 60.1 M | 59.7 M | 59.5 M | 56.4 M | 52.3 M | 52.1 M | 45.2 M | 44.2 M | 40.9 M | 40.1 M | 38.9 M | 36.8 M | 36 M | 35.9 M | 26 M | 13.1 M | 13.1 M | 13.1 M | 12.5 M | 11.8 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
- | - | -442 M | -117 M | - | -172 M | -211 M | -265 M | -218 M | -195 M | -181 M | -173 M | -149 M | -106 M | -211 M | -62.3 M | -54.8 M | -61.4 M | -39.3 M | -85.5 M | -27.1 M | -42.9 M | -38.4 M | -22.8 M | -25.5 M | -28.3 M | -6.82 M | -2.95 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
- | - | - | 319 M | - | 136 M | 92.9 M | 43.8 M | 35.1 M | 17.7 M | 9.7 M | 1.15 M | -1.77 M | - | - | - | -742 K | -697 K | -641 K | -728 K | -681 K | -638 K | -348 K | -218 K | -172 K | -75 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | 26.3 M | - | 25.5 M | 17.3 M | 12.9 M | 9.97 M | 4.24 M | 3.06 M | 424 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | 110 M | 75.6 M | 31 M | 25.1 M | 13.4 M | 6.64 M | 727 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
- | - | -290 M | -53.8 M | - | -140 M | -172 M | -236 M | -171 M | -163 M | -161 M | -151 M | -135 M | -90.5 M | -199 M | -54.5 M | -48.1 M | -54.9 M | -38.1 M | -83.4 M | -28.3 M | -39.6 M | -25.2 M | -14.5 M | -22.8 M | -28 M | -6.85 M | -2.98 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
- | - | 2.23 M | 81 K | - | -5 K | -3.05 M | -1.7 M | -743 K | -3.06 M | -119 K | -96 K | 3 K | 8 K | -16 K | -17 K | 5 K | 12 K | 13 K | 8 K | - | 239 K | 362 K | 305 K | 292 K | 93 K | 27 K | -3 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
- | - | -290 M | -49.4 M | - | -140 M | -172 M | -231 M | -171 M | -159 M | -159 M | -151 M | -135 M | -90 M | -199 M | -54.5 M | -48.1 M | -54.9 M | -38.1 M | -83.4 M | -28.3 M | -39.6 M | -25.2 M | -14.5 M | -22.8 M | -28 M | -6.84 M | -2.98 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
- | - | - | - | - | 250 M | 247 M | 267 M | 196 M | 177 M | 167 M | 152 M | 135 M | 90.5 M | 199 M | 54.5 M | 48.1 M | 54.9 M | 38.1 M | 83.4 M | 28.3 M | 39.6 M | 25.2 M | 14.5 M | 22.8 M | 28 M | 6.85 M | 2.98 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
- | - | - | 227 M | - | 165 M | 170 M | 160 M | 122 M | 120 M | 125 M | 95.6 M | 69 M | 28.8 M | 23.2 M | 13.5 M | 10.1 M | 7.57 M | 9.06 M | 7.86 M | 5.61 M | 4.57 M | 4.2 M | 3.76 M | 2.45 M | 920 K | 1.12 M | 613 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency